Critical Care Dx develops a diagnostic tool that enables detecting Concussion, Traumatic Brain Injury (TBI), and Spinal Cord Injury (SCI) by measuring quantitatively blood protein biomarkers. The business model is based on Sale per Unit. The tool is best suited for B2B channels such as provincial health authorities for catering to hospitals and clinics. For B2C, we partner with medical device distributors, leasing companies and sports teams.